Lunai Bioworks LNAI
NASDAQ LNAI
$1.30 -0.08 (-5.80%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lunai Bioworks (LNAI) Price to Sales (2026)

Updated

Lunai Bioworks' Price to Sales was 119.51 in fiscal Q3 2026 (quarter ended Mar 31, 2026).

Analysis

Lunai Bioworks (LNAI) Price to Sales (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Lunai Bioworks 4.31 Mn -440,776.51 20,942.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 106.15
API Access

Lunai Bioworks Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=LNAI&period=max&api_key=YOUR_API_KEY